These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18483189)

  • 21. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
    Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
    Reneman L; Majoie CB; Flick H; den Heeten GJ
    AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
    Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
    Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR spectroscopic imaging of normal-appearing white matter in adrenoleukodystrophy.
    Izquierdo M; Adamsbaum C; Benosman A; Aubourg P; Bittoun J
    Pediatr Radiol; 2000 Sep; 30(9):621-9. PubMed ID: 11009301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood white matter disorders: quantitative MR imaging and spectroscopy.
    van der Voorn JP; Pouwels PJ; Hart AA; Serrarens J; Willemsen MA; Kremer HP; Barkhof F; van der Knaap MS
    Radiology; 2006 Nov; 241(2):510-7. PubMed ID: 17057071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE; Mostert JP; Oudkerk M; De Keyser J
    Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton MR spectroscopy and neuropsychological testing in adrenoleukodystrophy.
    Rajanayagam V; Balthazor M; Shapiro EG; Krivit W; Lockman L; Stillman AE
    AJNR Am J Neuroradiol; 1997; 18(10):1909-14. PubMed ID: 9403453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.
    Kirov II; Liu S; Fleysher R; Fleysher L; Babb JS; Herbert J; Gonen O
    Radiology; 2010 Mar; 254(3):858-66. PubMed ID: 20177098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton MR spectroscopy of childhood adrenoleukodystrophy.
    Rajanayagam V; Grad J; Krivit W; Loes DJ; Lockman L; Shapiro E; Balthazor M; Aeppli D; Stillman AE
    AJNR Am J Neuroradiol; 1996; 17(6):1013-24. PubMed ID: 8791909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Mohamed MA; Lentz MR; Lee V; Halpern EF; Sacktor N; Selnes O; Barker PB; Pomper MG
    Radiology; 2010 Feb; 254(2):577-86. PubMed ID: 20093528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
    Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.